Company profile: VentureMed Group
1.1 - Company Overview
Company description
- Provider of vessel preparation systems and dynamic lesion engagement technology enabling interventionalists to treat peripheral artery disease and arteriovenous fistulas and grafts. Offerings include the FLEX Vessel Prep System using micro-incisions to modify plaque and stenosis and Dynamic Treatment Technology to improve vessel compliance and luminal gain.
Products and services
- Dynamic Treatment Technology: Interventional-grade platform that dynamically engages vascular lesions to create controlled micro-incisions, enhancing vessel compliance and luminal gain during peripheral interventions
- FLEX Vessel Prep System: Medical-grade vessel preparation device for peripheral artery disease and arteriovenous fistulas and grafts, utilizing micro-incisions to precisely modify plaque and stenosis within target vessels
- Interventional Device Design and Development: Custom-engineered service that designs and develops devices which enable interventionalists to cost effectively treat peripheral artery disease
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VentureMed Group
Voyage Medical
HQ: United States
Website
- Description: Provider of cardiac medical devices for the treatment of atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Voyage Medical company profile →
Acron Genomics
HQ: United Kingdom
Website
- Description: Provider of novel biotechnology platform development and commercialization in the life sciences, and of the introduction and development of promising new pharmaceutical compounds. U.S. publicly traded (OTC Markets/AGNM).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acron Genomics company profile →
Ancora Heart
HQ: United States
Website
- Description: Provider of the AccuCinch Ventricular Restoration System, a minimally invasive therapy for heart failure patients with reduced ejection fraction, aiming to reduce the size of the left ventricle and support its wall, and the CORCINCH-HF clinical study evaluating the safety and efficacy of AccuCinch in patients with symptomatic heart failure and reduced ejection fraction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ancora Heart company profile →
InnAVasc
HQ: United States
Website
- Description: Provider of medical devices for vascular access in hemodialysis, focusing on immediate access, home hemodialysis, and dialysis needle protection; offering the InnAVasc Graft with protective backplates and self-sealing materials to prevent needle injuries and bleeding complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnAVasc company profile →
Harpoon Medical
HQ: United States
Website
- Description: Provider of a minimally invasive, image-guided surgical tool for beating-heart mitral valve repair, developed in the Division of Cardiac Surgery at The University of Maryland School of Medicine; a development-stage medical device company commercializing the Harpoon device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harpoon Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VentureMed Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VentureMed Group
2.2 - Growth funds investing in similar companies to VentureMed Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VentureMed Group
4.2 - Public trading comparable groups for VentureMed Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →